{"entity":"bristol-myers-squibb","name":"Bristol-Myers Squibb","kind":"people","summary":"Bristol-Myers Squibb's timeline holds 7 people claims from 2018 to 2024. 1 is undated. The latest took effect on April 1, 2024.","counts":{"total":533,"by_kind":{"people":7,"money":514,"products":0,"models":0,"other":12}},"events":[{"date":null,"undated":true,"until":null,"published":"2026-03-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cfo: David V. Elkins\", undated. Claim clm_7B0B3B31B401, https://asof.is/claim/clm_7B0B3B31B401, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm.","url":"https://asof.is/claim/clm_7B0B3B31B401","accessed":"2026-11-10"},"kind":"people","predicate":"cfo","value":"David V. Elkins","status":"valid","assertable":true,"id":"clm_7B0B3B31B401","evidence":{"by":"page-read","on":"2026-11-09","quote":"David V. Elkins EVP and Chief Financial Officer Cristian Massacesi, M.D. EVP and Chief Medical Officer, Head of Development","url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm"}},{"date":"2018-01-01","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb board member: Karen Vousden\", as of 2018-01-01. Claim clm_DE68C9E1A6BA, https://asof.is/claim/clm_DE68C9E1A6BA, accessed 2026-11-10. Source: https://news.bms.com/news/details/2017/Bristol-Myers-Squibb-Names-Karen-Vousden-PhD-to-Board-of-Directors/default.aspx.","url":"https://asof.is/claim/clm_DE68C9E1A6BA","accessed":"2026-11-10"},"kind":"people","predicate":"board_member","value":"Karen Vousden","status":"valid","assertable":true,"id":"clm_DE68C9E1A6BA","evidence":{"by":"page-read","on":"2026-11-10","quote":"Bristol-Myers Squibb Company (NYSE:BMY) today announced that its Board of Directors has elected Karen Vousden, Ph.D., to the Board, effective January 1, 2018.","url":"https://news.bms.com/news/details/2017/Bristol-Myers-Squibb-Names-Karen-Vousden-PhD-to-Board-of-Directors/default.aspx"}},{"date":"2020-09-01","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb board member: Derica W. Rice\", as of 2020-09-01. Claim clm_EABE01FA350D, https://asof.is/claim/clm_EABE01FA350D, accessed 2026-11-10. Source: https://news.bms.com/news/details/2020/Bristol-Myers-Squibb-Board-Elects-Two-New-Independent-Directors/default.aspx.","url":"https://asof.is/claim/clm_EABE01FA350D","accessed":"2026-11-10"},"kind":"people","predicate":"board_member","value":"Derica W. Rice","status":"valid","assertable":true,"id":"clm_EABE01FA350D","evidence":{"by":"page-read","on":"2026-11-10","quote":"Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected two new independent directors, Ms. Paula A. Price and Mr. Derica W. Rice, who will join the Board, effective September 1, 2020.","url":"https://news.bms.com/news/details/2020/Bristol-Myers-Squibb-Board-Elects-Two-New-Independent-Directors/default.aspx"}},{"date":"2021-06-01","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb board member: Manuel Hidalgo Medina\", as of 2021-06-01. Claim clm_F84214FDEDF2, https://asof.is/claim/clm_F84214FDEDF2, accessed 2026-11-10. Source: https://news.bms.com/news/details/2021/Bristol-Myers-Squibb-Elects-Manuel-Hidalgo-Medina-M.D.-Ph.D.-to-Board-of-Directors/default.aspx.","url":"https://asof.is/claim/clm_F84214FDEDF2","accessed":"2026-11-10"},"kind":"people","predicate":"board_member","value":"Manuel Hidalgo Medina","status":"valid","assertable":true,"id":"clm_F84214FDEDF2","evidence":{"by":"page-read","on":"2026-11-10","quote":"Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected Manuel Hidalgo Medina, M.D., Ph.D., to the Board, effective June 1, 2021.","url":"https://news.bms.com/news/details/2021/Bristol-Myers-Squibb-Elects-Manuel-Hidalgo-Medina-M.D.-Ph.D.-to-Board-of-Directors/default.aspx"}},{"date":"2022-06-14","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb board member: Deepak L. Bhatt\", as of 2022-06-14. Claim clm_B50E3002E109, https://asof.is/claim/clm_B50E3002E109, accessed 2026-11-10. Source: https://news.bms.com/news/details/2022/Bristol-Myers-Squibb-Elects-Deepak-L.-Bhatt-M.D.-M.P.H.-to-Board-of-Directors/default.aspx.","url":"https://asof.is/claim/clm_B50E3002E109","accessed":"2026-11-10"},"kind":"people","predicate":"board_member","value":"Deepak L. Bhatt","status":"valid","assertable":true,"id":"clm_B50E3002E109","evidence":{"by":"page-read","on":"2026-11-10","quote":"Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected Deepak L. Bhatt, M.D., MPH., to the Board, effective June 14, 2022.","url":"https://news.bms.com/news/details/2022/Bristol-Myers-Squibb-Elects-Deepak-L.-Bhatt-M.D.-M.P.H.-to-Board-of-Directors/default.aspx"}},{"date":"2023-11-01","until":null,"published":"2026-03-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb ceo: Christopher S. Boerner, Ph.D\", as of 2023-11-01. Claim clm_FF61856A3386, https://asof.is/claim/clm_FF61856A3386, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm.","url":"https://asof.is/claim/clm_FF61856A3386","accessed":"2026-11-10"},"kind":"people","predicate":"ceo","value":"Christopher S. Boerner, Ph.D","status":"valid","assertable":true,"id":"clm_FF61856A3386","evidence":{"by":"page-read","on":"2026-11-08","quote":"Christopher S. Boerner, Ph.D. Board Chair & Chief Executive Officer of the Company Director Since: 2023 Age: 55 Board Committees • None Other Public Company Boards • Colgate-Palmolive Company Experience • Bristol Myers Squibb, Chief Executive Officer (November 2023-present)","url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm"}},{"date":"2024-04-01","until":null,"published":"2026-03-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb chair: Christopher S. Boerner, Ph.D\", as of 2024-04-01. Claim clm_62358F2F8937, https://asof.is/claim/clm_62358F2F8937, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm.","url":"https://asof.is/claim/clm_62358F2F8937","accessed":"2026-11-10"},"kind":"people","predicate":"chair","value":"Christopher S. Boerner, Ph.D","status":"valid","assertable":true,"id":"clm_62358F2F8937","evidence":{"by":"page-read","on":"2026-11-08","quote":"Christopher S. Boerner, Ph.D. Board Chair & Chief Executive Officer of the Company Director Since: 2023 Age: 55 Board Committees • None Other Public Company Boards • Colgate-Palmolive Company Experience • Bristol Myers Squibb, Chief Executive Officer (November 2023-present) • Board Chair (April 2024","url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm"}}],"complete":true,"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"page-read":"its source page states the value and the date"}}}